Literature DB >> 27117237

Alcohol-Induced Stimulation Mediates the Effect of a GABRA2 SNP on Alcohol Self-Administrated among Alcohol-Dependent Individuals.

Stephen J Boyd1, Joseph P Schacht1, James J Prisciandaro1, Konstantin Voronin1, Raymond F Anton2.   

Abstract

BACKGROUND: A single-nucleotide polymorphism (SNP) in GABRA2 (rs279858) may moderate subjective response (SR) to alcohol. Results of studies in non-dependent drinkers examining this GABRA2 SNP on SR have been equivocal. This study examined this SNP's direct and indirect effects on alcohol self-administration in dependent drinkers.
METHOD: The sample consisted of 63 Caucasian, non-treatment-seeking individuals with alcohol dependence. Subjective stimulation was assessed using the Biphasic Alcohol Effects Scale following consumption of an alcoholic priming drink (target breath alcohol content = 0.02 g%). Participants were subsequently offered the opportunity to self-administer up to eight additional drinks.
RESULTS: Controlling for baseline stimulation, T-allele homozygotes, relative to individuals with at least one copy of the C-allele, reported greater initial stimulation, t(58) = 2.011, p = 0.049. Greater stimulation predicted greater subsequent alcohol self-administration, t(57) = 2.522, p = 0.015. Although rs279858 genotype did not directly impact self-administration (t(57) = -0.674, p = 0.503), it did have an indirect effect (95% confidence interval [0.068, 1.576]), such that T-allele homozygotes reported greater stimulation, which in turn predicted greater self-administration.
CONCLUSION: These results suggest that the influence of this SNP on SR differs depending on dose or stage of dependence. This study is the first to demonstrate an indirect effect of rs279858 genotype on drinking through SR. Although C-allele carriers have been shown to have an increased risk for alcohol dependence, in our dependent sample, greater stimulation was found among T-allele homozygotes, suggesting that the influence of SR on developing and maintaining dependence differs based on rs279858 genotype.This study demonstrates an indirect effect of rs279858 genotype on drinking through SR. Although C-allele carriers have an increased risk for alcohol dependence, in our dependent sample, greater stimulation was found among T-allele homozygotes, suggesting that the influence of SR on developing dependence differs based on rs279858 genotype.
© The Author 2016. Medical Council on Alcohol and Oxford University Press. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27117237      PMCID: PMC5004744          DOI: 10.1093/alcalc/agw024

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  37 in total

1.  Testing the level of response to alcohol: social information processing model of alcoholism risk--a 20-year prospective study.

Authors:  Marc A Schuckit; Tom L Smith; Kristen G Anderson; Sandra A Brown
Journal:  Alcohol Clin Exp Res       Date:  2004-12       Impact factor: 3.455

2.  Meta-analyses of ALDH2 and ADH1B with alcohol dependence in Asians.

Authors:  Susan E Luczak; Stephen J Glatt; Tamara L Wall
Journal:  Psychol Bull       Date:  2006-07       Impact factor: 17.737

3.  Convergence of genome-wide association and candidate gene studies for alcoholism.

Authors:  Emily Olfson; Laura Jean Bierut
Journal:  Alcohol Clin Exp Res       Date:  2012-09-14       Impact factor: 3.455

Review 4.  Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism.

Authors:  Lara A Ray; James Mackillop; Peter M Monti
Journal:  Subst Use Misuse       Date:  2010-09       Impact factor: 2.164

5.  Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.

Authors:  Raymond F Anton; Konstantin K Voronin; Patrick K Randall; Hugh Myrick; Abraham Tiffany
Journal:  Alcohol Clin Exp Res       Date:  2012-05-02       Impact factor: 3.455

6.  A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans.

Authors:  Lara A Ray; Kent E Hutchison
Journal:  Alcohol Clin Exp Res       Date:  2004-12       Impact factor: 3.455

7.  Biphasic stimulant and sedative effects of ethanol: are children of alcoholics really different?

Authors:  Joel Erblich; Mitchell Earleywine; Bryna Erblich; Dana H Bovbjerg
Journal:  Addict Behav       Date:  2003-08       Impact factor: 3.913

8.  Allelic and haplotypic association of GABRA2 with alcohol dependence.

Authors:  Jonathan Covault; Joel Gelernter; Victor Hesselbrock; Maggie Nellissery; Henry R Kranzler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-08-15       Impact factor: 3.568

9.  A GABRA2 variant is associated with increased stimulation and 'high' following alcohol administration.

Authors:  Albert J Arias; Jonathan Covault; Richard Feinn; Timothy Pond; Bao-Zhu Yang; Wenjing Ge; Cheryl Oncken; Henry R Kranzler
Journal:  Alcohol Alcohol       Date:  2013-10-27       Impact factor: 2.826

10.  A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene.

Authors:  David J Drobes; Raymond F Anton; Suzanne E Thomas; Konstantin Voronin
Journal:  Neuropsychopharmacology       Date:  2002-10-30       Impact factor: 7.853

View more
  3 in total

Review 1.  Combined and sequential effects of alcohol and methamphetamine in animal models.

Authors:  Alexandra M Stafford; Bryan K Yamamoto; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2021-09-17       Impact factor: 8.989

2.  Does Self-Reported or Behavioral Impulsivity Predict Subjective Response to Low-Dose Alcohol?

Authors:  Benjamin L Berey; Robert F Leeman; Brian Pittman; Nicholas Franco; Suchitra Krishnan-Sarin
Journal:  Alcohol Alcohol       Date:  2019-03-01       Impact factor: 2.826

Review 3.  GABAA receptor polymorphisms in alcohol use disorder in the GWAS era.

Authors:  Mairi Koulentaki; Elias Kouroumalis
Journal:  Psychopharmacology (Berl)       Date:  2018-05-02       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.